Clinical trial condition

MSS

Explore clinical trials studying MSS. Study availability and eligibility vary by location and protocol.

12 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

MSS trial results

Recruiting

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

NCT06321081

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Beijing Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT)

NCT06908031

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

NCT07549399

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

NCT06850103

Conditions: Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +13 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

NCT05731726

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Second Affiliated Hospital School of Medicine Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

NCT07001592

Conditions: DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, +27 more
Locations: AHN West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

NCT05877573

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

NCT06593548

Conditions: CRC, MSS, Metastatic Cancer, +5 more
Locations: Xinxiang Li Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

NCT06199232

Conditions: Failed From Standard Treatment, Liver Metastasis Colon Cancer, MSS, +1 more
Locations: Peking Univerisity Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC

NCT03274804

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: National Center for Tumor Diseases, University Hospital Heidelberg Heidelberg, Germany

View Trial Details

MSS

MSS trial results

Related conditions